600223.SH
Lushang Freda Pharmaceutical Co., Ltd.
SSE · Healthcare · Real Estate - Development · CN
CNY 5.37
−1.29%Oct 13, 2026, 08:23 UTC
Furida said director Zhou Ming and deputy general manager Gao Chunming left their positions for age-related reasons.
Source:Aug 25, 2026, 08:49 UTC
Furida announced its 2026 half-year results: revenue of 1.909 billion yuan, up 6.69% year-on-year; net profit attributable to shareholders of 81.7815 million yuan, down 24.25% year-on-year; and no interim dividend or capital reserve conversion.
Source:Jul 17, 2026, 08:53 UTC
SONG JIANBO increased his stake in Hengtong Co., Ltd. to 5% via block trading on July 17, 2026, and plans further purchases.
Source: